Development of a Risk Stratification Model for Coronary In-Stent Restenosis Based on Clinical, Laboratory, and Procedural Factors: A Case-Control Study. [PDF]
Zemlyanskaya N +6 more
europepmc +1 more source
Percutaneous coronary intervention in cardiac allograft vasculopathy: From lesion selection to longitudinal graft management. [PDF]
Dharan A +6 more
europepmc +1 more source
Monocyte Transcriptional Reprogramming Explains Refractory In-Stent Restenosis. [PDF]
Bednarek J, Ibla J, Thorp EB.
europepmc +1 more source
Single-Cell Transcriptomics Reveals the Immune Pathogenesis of Isolated Coronary Arteritis Presenting as Refractory In-Stent Restenosis. [PDF]
Yu M +15 more
europepmc +1 more source
Anterior ST-Segment Elevation From Nondominant Right Coronary Artery Occlusion: Lessons From Two Cases. [PDF]
Ayesh H, Al-Shaer M, Alsleibi S.
europepmc +1 more source
Recognizing Early Career Translational Investigators. [PDF]
Nahrendorf M.
europepmc +1 more source
Molecular profiling of coronary stent restenosis. A systematic review and functional analysis of implicated genes: Erratum. [PDF]
El Mansouri R, Habbal R, Dehbi H.
europepmc +1 more source
Predictive value of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for in-stent restenosis after drug-eluting stent implantation in patients with coronary heart disease. [PDF]
Tuersun T +3 more
europepmc +1 more source
Predictive value of remnant cholesterol for in-stent restenosis after drug-eluting stent implantation. [PDF]
Yimamu A +4 more
europepmc +1 more source

